Published in Hepatitis Weekly, May 8th, 1995
The inactivated vaccine, manufactured by SmithKline Beecham Biologicals, Philadelphia, Pennsylvania, is being marketed under the name Havrix. A second vaccine against hepatitis A, made by Merck Sharp and Dohme Research Laboratories of West Point, Pennsylvania, is also under active investigation by the FDA.
According to a March 29, 1995, article in Journal of the American Medical Association, recommendations for use of the licensed vaccine are being prepared by the Hepatitis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly